PortfoliosLab logoPortfoliosLab logo
XNR
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Diversification

Asset Allocation


NVO 50.00%AAPL 30.00%TSM 20.00%EquityEquity

S&P 500 Index

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in XNR, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends. The portfolio is rebalanced Every 3 months.


Loading graphics...

The earliest data available for this chart is Oct 9, 1997, corresponding to the inception date of TSM

Returns By Period

As of Apr 4, 2026, the XNR returned -11.73% Year-To-Date and 18.96% of annualized return in the last 10 years.


1D1MYTD6M1Y3Y*5Y*10Y*
Benchmark
S&P 500 Index
0.11%-4.18%-3.84%-1.98%21.98%16.86%10.37%12.29%
Portfolio
XNR
0.56%-2.43%-11.73%-16.20%0.02%5.61%14.56%18.96%
NVO
Novo Nordisk A/S
1.37%-0.59%-24.78%-35.82%-42.32%-20.60%3.97%5.03%
TSM
Taiwan Semiconductor Manufacturing Company Limited
-0.72%-4.88%11.88%16.66%118.04%56.27%24.16%32.63%
AAPL
Apple Inc
0.11%-2.51%-5.78%-0.62%26.50%16.04%16.39%26.10%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Monthly Returns

Based on dividend-adjusted daily data since Oct 10, 1997, XNR's average daily return is +0.10%, while the average monthly return is +1.96%. At this rate, your investment would double in approximately 3.0 years.

Historically, 65% of months were positive and 35% were negative. The best month was Jan 2001 with a return of +28.0%, while the worst month was Jul 2002 at -24.0%. The longest winning streak lasted 13 consecutive months, and the longest losing streak was 7 months.

On a daily basis, XNR closed higher 53% of trading days. The best single day was Oct 13, 2008 with a return of +12.9%, while the worst single day was Sep 29, 2000 at -16.5%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20268.78%-16.55%-3.36%0.63%-11.73%
2025-1.46%1.50%-15.50%-3.38%5.46%2.95%-14.22%11.66%7.12%-2.02%0.28%1.49%-9.30%
20245.93%4.64%4.18%-0.05%8.59%8.76%-2.85%4.29%-6.20%-2.00%-1.29%-5.43%18.53%
20239.42%0.09%11.83%1.50%2.38%3.97%-0.19%5.55%-4.64%2.87%8.60%2.69%52.51%
2022-5.52%-2.96%5.80%-3.74%-2.75%-4.57%9.30%-6.05%-10.21%5.84%12.44%-0.69%-5.57%
20211.96%-0.37%-3.14%6.82%1.94%6.61%6.63%6.07%-5.13%9.49%2.02%5.33%44.22%

Benchmark Metrics

XNR has an annualized alpha of 18.05%, beta of 0.89, and R² of 0.44 versus S&P 500 Index. Calculated based on daily prices since October 10, 1997.

  • This portfolio captured 153.00% of S&P 500 Index gains but only 79.87% of its losses — a favorable profile for investors.
  • R² of 0.44 means the benchmark explains less than half of this portfolio's behavior — treat beta with caution or consider switching to a more representative benchmark.

Alpha
18.05%
Beta
0.89
0.44
Upside Capture
153.00%
Downside Capture
79.87%

Expense Ratio

XNR has an expense ratio of 0.00%, meaning no management fees are charged. Below, you can find the expense ratios of the portfolio's funds side by side and easily compare their relative costs.


The portfolio doesn't include any funds that charge management fees.

Return for Risk

Risk / Return Rank

XNR ranks 4 for risk / return — in the bottom 4% of portfolios on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.


XNR Risk / Return Rank: 44
Overall Rank
XNR Sharpe Ratio Rank: 33
Sharpe Ratio Rank
XNR Sortino Ratio Rank: 33
Sortino Ratio Rank
XNR Omega Ratio Rank: 33
Omega Ratio Rank
XNR Calmar Ratio Rank: 55
Calmar Ratio Rank
XNR Martin Ratio Rank: 55
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics


PortfolioBenchmarkDifference

Sharpe ratio

Return per unit of total volatility

-0.15

0.88

-1.04

Sortino ratio

Return per unit of downside risk

0.02

1.37

-1.35

Omega ratio

Gain probability vs. loss probability

1.00

1.21

-0.21

Calmar ratio

Return relative to maximum drawdown

-0.19

1.39

-1.57

Martin ratio

Return relative to average drawdown

-0.46

6.43

-6.89


How much return does each position deliver for the risk it carries? Higher values mean better reward for the risk taken.

Risk / Return RankSharpe ratioSortino ratioOmega ratioCalmar ratioMartin ratio
NVO
Novo Nordisk A/S
10-0.80-0.970.87-0.78-1.35
TSM
Taiwan Semiconductor Manufacturing Company Limited
932.643.231.415.7018.99
AAPL
Apple Inc
550.470.921.130.662.04

Sharpe Ratio

The Sharpe ratio helps investors understand how much return they're getting for the level of risk taken. A higher Sharpe ratio indicates better risk-adjusted performance, meaning more reward for each unit of risk.

XNR Sharpe ratios as of Apr 4, 2026 (values are recalculated daily):

  • 1-Year: -0.15
  • 5-Year: 0.58
  • 10-Year: 0.81
  • All Time: 0.89

These values reflect how efficiently the investment has delivered returns relative to its volatility over different time periods. All figures are annualized and based on daily total returns (including price changes and dividends).

Compared to the broad market, where average Sharpe ratios range from 0.99 to 1.69, this portfolio's current Sharpe ratio places it in the bottom 25%. This suggests weaker risk-adjusted returns than most portfolios, possibly due to lower returns, higher volatility, or both. It may be worth reviewing the allocation. You can use the Portfolio Optimization tool to explore options for improving the Sharpe ratio.

The chart below shows the rolling Sharpe ratio of XNR compared to the selected benchmark. This view highlights how the investment's risk-adjusted performance has changed over time.


Loading graphics...

Dividends

Dividend yield

XNR provided a 2.75% dividend yield over the last twelve months.


TTM20252024202320222021202020192018201720162015
Portfolio2.75%1.97%1.20%1.00%1.31%1.13%1.43%2.07%1.99%1.66%2.54%1.55%
NVO
Novo Nordisk A/S
4.87%3.31%1.68%1.00%1.20%1.35%1.87%2.14%1.45%1.52%2.87%0.92%
TSM
Taiwan Semiconductor Manufacturing Company Limited
0.98%1.00%1.18%1.78%2.49%1.57%1.56%3.46%3.64%2.32%2.61%2.54%
AAPL
Apple Inc
0.41%0.38%0.40%0.49%0.70%0.49%0.61%1.04%1.79%1.45%1.93%1.93%

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading graphics...

Worst Drawdowns

The table below displays the maximum drawdowns of the XNR. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the XNR was 53.82%, occurring on Aug 5, 2002. Recovery took 474 trading sessions.

The current XNR drawdown is 33.81%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-53.82%Aug 29, 2000483Aug 5, 2002474Jun 23, 2004957
-44.09%May 19, 2008131Nov 20, 2008209Sep 22, 2009340
-40.84%Jul 11, 2024187Apr 8, 2025
-25.12%Feb 7, 202030Mar 20, 202051Jun 3, 202081
-22.36%Jul 21, 2015335Nov 14, 2016116May 3, 2017451

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading graphics...

Diversification

Diversification Metrics


Number of Effective Assets

The portfolio contains 3 assets, with an effective number of assets of 2.63, reflecting the diversification based on asset allocation. This number of effective assets suggests a highly concentrated portfolio, where a few assets dominate the allocation, potentially increasing the portfolio's risk due to lack of diversification.

Asset Correlations Table

The table below displays the correlation coefficients between the individual components of the portfolio, the entire portfolio, and the chosen benchmark.

BenchmarkNVOTSMAAPLPortfolio
Benchmark1.000.340.560.570.63
NVO0.341.000.230.190.72
TSM0.560.231.000.400.63
AAPL0.570.190.401.000.68
Portfolio0.630.720.630.681.00
The correlation results are calculated based on daily price changes starting from Oct 10, 1997